SCHEMBL2223767

SCHEMBL2223767

CC(C)(C)SCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8725908 0.82 CYP2D6 (0.45)
SCHEMBL6701234 0.82 CYP2D6 (0.45)
SCHEMBL2933753 0.79 HTR1A (0.32)
SCHEMBL8608901 0.78 TSHR (0.52)
SCHEMBL724252 0.78 OR51E2 (0.35)
SCHEMBL9174852 0.78 CYP2D6 (0.41)
SCHEMBL3461929 0.77
SCHEMBL11438338 0.74 PTGES (0.35)
SCHEMBL20173442 0.74
SCHEMBL3085260 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250290891-A1 SYSTEMS AND METHODS FOR POINT-OF-CARE ELECTROCHEMICAL DETECTION OF BIOMARKERS IN LIQUIDS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2025-09-18 US claimed
US-20240230571-A1 VOLATILE COMPOUND SOURCE LOCATING SYSTEMS US DEPARTMENT OF ENERGY 2024-07-11 US claimed
US-20120326092-A1 VOLATILE ORGANIC COMPOUNDS AS DIAGNOSTIC MARKERS FOR VARIOUS TYPES OF CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2012-12-27 US claimed
WO-2011083473-A1 VOLATILE ORGANIC COMPOUNDS AS DIAGNOSTIC MARKERS FOR VARIOUS TYPES OF CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2011-07-14 WO claimed
US-20250375123-A1 ANALYSIS OF GAS SAMPLES FOR DETERMINATION OF PHYSIOLOGICAL STATES AND DISEASE STATES UNIV NEW YORK (US) 2025-12-11 US disclosed
US-20250290891-A1 SYSTEMS AND METHODS FOR POINT-OF-CARE ELECTROCHEMICAL DETECTION OF BIOMARKERS IN LIQUIDS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2025-09-18 US disclosed
US-20240210389-A1 THREE-DIMENSIONAL PERCOLATION ARRAY STRUCTURE AS A GAS SENSOR U.S. DEPARTMENT OF ENERGY 2024-06-27 US disclosed
US-11796428-B2 Compressed open flow assay and use ESSENLIX CORPORATION (US) 2023-10-24 US disclosed
US-11701031-B2 Molecularly-imprinted electrochemical sensors NORTHEASTERN UNIVERSITY (US) 2023-07-18 US disclosed
US-20230077906-A1 ASSAY FOR VAPOR CONDENSATES ESSENLIX CORPORATION (US) 2023-03-16 US disclosed
US-11523752-B2 Assay for vapor condensates ESSENLIX CORPORATION (US) 2022-12-13 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-1090013-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
US-6110896-A TRIPEPTIDYL DERIVATIVES HAVING A MERCAPTO OR ACYLTHIO GROUP AND WHICH ARE AMIDES; UTILITY AS MATRIX METALLOPROTEASE OR TNF INHIBITORS DARWIN DISCOVERY, LTD. (GB) 2000-08-29 US disclosed
WO-1999067255-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-12-29 WO disclosed
EP-0826000-A1 PEPTIDE COMPOUNDS WHICH INHIBIT METALLOPROTEINASE AND TNF LIBERATION AND THEIR THERAPEUTIC USES Chiroscience Limited (GB) 1998-03-04 EP disclosed
WO-1996035714-A1 PEPTIDE COMPOUNDS WHICH INHIBIT METALLOPROTEINASE AND TNF LIBERATION AND THEIR THERAPEUTIC USES CHIROSCIENCE LIMITED (GB) 1996-11-14 WO disclosed
EP-0516980-B1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors MERRELL PHARMA INC (US) 1996-04-17 EP disclosed
US-5252601-A 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1993-10-12 US disclosed
EP-0516980-A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors MERRELL PHARMACEUTICALS INC. (US) 1992-12-09 EP disclosed